Smart scales could help keep blood cancer patients safe at home
NCT ID NCT06133426
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at whether a connected scale can help monitor blood cancer patients (with lymphoma or myeloma) during chemotherapy. Thirty patients will weigh themselves daily for about 7 weeks, and their data will be sent to their medical team. The goal is to see if this approach is feasible and if it helps catch problems early.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
connected scale device
What this could lead to
If successful, this could show that remote monitoring with a connected scale helps detect health changes early in blood cancer patients, potentially improving care.
What could go wrong
This is a small, early feasibility study with only 30 participants and no comparison group, so results may not apply broadly. The device may not be easy for all patients to use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA, NON-HODGKIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cochin Hospital
RECRUITINGParis, 75014, France
Contact Phone: •••-•••-•••• Email: •••••@•••••